Hello from San Francisco! BioSpace is reporting from #JPM2024 bringing you key takeaways and highlights from day one.
Join Lori, Greg and Tyler as they discuss what&#39;s moving and shaking. 
You can <a href="https://www.biospace.com/article/jpm-2024-on-the-ground-in-san-francisco/">⁠follow our coverage⁠</a> as our team adds updates throughout the day.
Get Greg&#39;s take on <a href="https://www.biospace.com/article/jpm-offers-first-glimpse-of-what-2024-might-portend-for-biopharma-sector/">⁠what this year might hold⁠</a> in store and how the Biden administration&#39;s policies may <a href="https://www.biospace.com/article/biopharma-policy-in-the-spotlight-at-jpm-as-sector-gears-up-for-volatile-2024/">⁠play a role in discussions⁠</a>.
Join us tomorrow for Day 2 highlights!

On the ground at #JPM2024 - Day 2 highlights

Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether it’s layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development.